Mutations consisting of internal tandem duplications (ITDs) in exons 11 and 12 of the proto-oncogene c-kit are found in 30–50% of malignant canine mast cell tumors (MCTs). Traditionally, identification of such mutations in tumor specimens has been undertaken using standard polymerase chain reaction (PCR) and agarose gel electrophoresis. This procedure is limited to the detection of insertions and deletions larger than 9 base pairs in size. The purpose of this study was to compare the efficiency and accuracy of standard agarose gel electrophoresis with fluorescent polyacrylamide gel electrophoresis (PAGE) for the detection of ITDs in canine MCTs. The results of this study demonstrate that PAGE of labeled PCR products accurately predicts the size of the ITD in each tumor. In addition, other small insertions and deletions were not identified, suggesting that if they occur in canine MCTs, they do so infrequently. Because fluorescent and polyacrylamide formats are automated and have better resolution than agarose gels, fluorescent PAGE provides a more accurate, economical, and higher throughput method for the detection of c-kit mutations in canine MCTs.
References
1.
al-SarrafRMauldinGNPatnaikAKMeleoKA: 1996, A prospective study of radiation therapy for the treatment of grade 2 MCTs in 32 dogs. J Vet Intern Med10:376–378.
2.
BesmerPMurphyJEGeorgePC: 1986, A new acute transforming feline retrovirus and relationship of its oncogene v-kit with the protein kinase gene family. Nature320:415–421.
3.
BostockDE: 1986, Neoplasms of the skin and subcutaneous tissues in dogs and cats. Br Vet J142:1–19.
4.
ButtnerCHenzBMWelkerP: 1998, Identification of activating c-kit mutations in adult-, but not in childhood-onset indolent mastocytosis: a possible explanation for divergent clinical behavior. J Invest Dermatol111:1227–1231.
5.
CohenDReifSSBrodeyRS: 1974, Epidemiological analysis of the most prevalent sites and types of canine neoplasia observed in a veterinary hospital. Cancer Res34:2859–2868.
6.
DowningSChienMBKassPH: 2002, Prevalence and importance of internal tandem duplications in exons 11 and 12 of c-kit in mast cell tumors of dogs. Am J Vet Res63:1718–1723.
7.
FrimbergerAEMooreASLaRueSM: 1997, Radiotherapy of incompletely resected, moderately differentiated mast cell tumors in the dog: 37 cases (1989–1993). J Am Anim Hosp Assoc33:320–324.
8.
FuritsuTTsujimuraTTonoT: 1993, Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand independent activation of c-kit product. J Clin Invest92:1736–1744.
9.
GalliSJZseboKMGeisslerEN: 1994, The kit ligand, stem cell factor. Adv Immunol55:1–95.
10.
LondonCAGalliSJYuukiT: 1999, Spontaneous canine mast cell tumors express tandem duplications in the proto-oncogene c-kit. Exp Hematol27:689–697.
11.
LongleyBJMaYCarterEMcMahonG: 2000, New approaches to therapy for mastocytosis. A case for treatment with kit kinase inhibitors. Hematol Oncol Clin North Am14:689–695.
12.
LongleyBJJr.MetcalfeDDTharpM: 1999, Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis. Proc Natl Acad Sci USA96:1609–1614.
13.
MaYLongleyBJWangX: 1999, Clustering of activating mutations in c-KIT's juxtamembrane coding region of canine mast cell neoplasms. J Invest Dermatol112:165–170.
NagataHOkadaTWorobecAS: 1997, c-kit mutation in a population of patients with mastocytosis. Int Arch Allergy Immunol113:184–186.
18.
NockaKBuckJLeviEBesmerP: 1990, Candidate ligand for the c-kit transmembrane kinase receptor: KL, a fibroblast derived growth factor stimulates mast cells and erythroid progenitors. EMBO J10:3287–3294.
19.
PatnaikAKEhlerWJMacEwenEG: 1984, Canine cutaneous mast cell tumors: morphologic grading and survival time in 83 dogs. Vet Pathol21:469–474.
20.
PriesterWA: 1973, Skin tumors in domestic animals. Data from 21 US and Canadian colleges of veterinary medicine. J Natl Cancer Inst50:457–466.
21.
SeguinBLeibmanNFBregazziVS: 2001, Clinical outcome of dogs with grade-II mast cell tumors treated with surgery alone: 55 cases (1996–1999). J Am Vet Med Assoc218:1120–1123.
22.
SimoesJPSchoningPButineM: 1994, Prognosis of canine mast cell tumors: a comparison of three methods. Vet Pathol31:637–647.
23.
ToonenRJHughesS: 2001, Increased throughput for fragment analysis on an ABI PRISM 377 automated sequencer using a membrane comb and STRand software. Biotechniques31:1320–1324.
24.
TravisWDLiC-Y: 1993, Mast cell diseases. In: The mast cell in health and disease, ed. KalinerMAMetcalfeDD, pp. 723–741. Marcel Dekker Inc, New York, NY.
25.
TsujimuraTFuritsuTMorimotoM: 1994, Ligand-independent activation of c-kit receptor tyrosine kinase in a murine mastocytoma cell line P815 generated by a point mutation. Blood83:2619–2626.
26.
TsujimuraTFuritsuTMorimotoM: 1995, Substitution of an aspartic acid results in constitutive activation of c-kit receptor tyrosine kinase in a rat tumor mast cell line RBL-2H3. Int Arch Allergy Immunol106:377–385.
27.
TsujimuraTMorimotoMHashimotoK: 1996, Constitutive activation of c-kit in FMA3 murine mastocytoma cells caused by deletion of seven amino acids at the juxtamembrane domain. Blood87:273–283.
28.
WorobecASSemereTNagataHMetcalfeDD: 1998, Clinical correlates of the presence of the Asp816Val c-kit mutation in the peripheral blood mononuclear cells of patients with mastocytosis. Cancer83:2120–2129.
29.
YardenYKuangWJYang-FongT: 1987, Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J6:3341–3351.
30.
ZemkeDYaminiBYuzbasiyan-GurkanV: 2001, Characterization of an undifferentiated malignancy as a mast cell tumor using mutation analysis in the proto-oncogene c-KIT. J Vet Diagn Invest13:341–345.
31.
ZemkeDYaminiBYuzbasiyan-GurkanV: 2002, Mutations in the juxtamembrane domain of c-KIT are associated with higher grade mast cell tumors in dogs. Vet Pathol39:529–535.
32.
ZseboKMWilliamsDAGeisslerEN: 1990, Stem cell factor is encoded at the SI locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor. Cell633:213–224.
33.
ZseboKMWypychJMcNieceIK: 1990, Identification, purification, and biological characterization of hematopoeitic stem cell factor from buffalo rat liver-conditioned medium. Cell63:195–201.
